• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Forte Biosciences, Inc. - Common Stock (NQ:FBRX)

    27.45 -1.41 (-4.89%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 189,031
    Open 28.22
    Bid (Size) 27.46 (100)
    Ask (Size) 39.90 (200)
    Prev. Close 28.86
    Today's Range 27.17 - 28.48
    52wk Range 5.800 - 35.80
    Shares Outstanding 21,051,195
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Which stocks are experiencing notable movement on Thursday? ↗
    Via Chartmill
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill

    Performance

    YTD
    +16.3%
    +16.3%
    1 Month
    +4.1%
    +4.1%
    3 Month
    -13.9%
    -13.9%
    6 Month
    +126.7%
    +126.7%
    1 Year
    +294.4%
    +294.4%

    More News

    Read More
    News headline image
    Forte Biosciences, Inc. Announces 2025 Results and Provides Update
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences Tops Q2 Loss Forecasts ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Forte Biosciences, Inc. Announces Results and Provides Update
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Forte Biosciences Announces Pricing of $75 Million Public Offering
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Forte Biosciences Announces Proposed Public Offering
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Forte Biosciences, Inc. Announces Results and Provides Update
    From Forte Biosciences, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Forte Biosciences, Inc. - Common Stock publicly traded?
    Yes, Forte Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Forte Biosciences, Inc. - Common Stock trade on?
    Forte Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Forte Biosciences, Inc. - Common Stock?
    The ticker symbol for Forte Biosciences, Inc. - Common Stock is FBRX on the Nasdaq Stock Market
    What is the current price of Forte Biosciences, Inc. - Common Stock?
    The current price of Forte Biosciences, Inc. - Common Stock is 27.45
    When was Forte Biosciences, Inc. - Common Stock last traded?
    The last trade of Forte Biosciences, Inc. - Common Stock was at 04/24/26 04:00 PM ET
    What is the market capitalization of Forte Biosciences, Inc. - Common Stock?
    The market capitalization of Forte Biosciences, Inc. - Common Stock is 577.86M
    How many shares of Forte Biosciences, Inc. - Common Stock are outstanding?
    Forte Biosciences, Inc. - Common Stock has 578M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.